The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Aprepitant API Market Research Report 2025
Synopsis
The global market for Aprepitant API was valued at US$ 423 million in the year 2024 and is projected to reach a revised size of US$ 574 million by 2031, growing at a CAGR of 4.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aprepitant API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant API.
The Aprepitant API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aprepitant API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JUBILANT GENERICS LTD
PIRAMAL PHARMA LTD
MSN LABORATORIES PRIVATE LTD
HETERO DRUGS LTD
DR REDDYS LABORATORIES LTD
GLENMARK LIFE SCIENCES LTD
INKE SA
WISDOM PHARMACEUTICAL CO LTD
VIWIT PHARMACEUTICAL CO LTD
NAVINTA LLC
PHARMATHEN SA
SCINOPHARM TAIWAN LTD
AUROBINDO PHARMA LTD
WOCKHARDT BIO AG
SOLARA ACTIVE PHARMA SCIENCES LTD
OLON SPA
SHANDONG ANXIN PHARMACEUTICAL CO LTD
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
by Type
Purity≥99%
Purity<99%
by Application
Injection
Capsule
Emulsion
Oral Suspension
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Aprepitant API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Aprepitant API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Aprepitant API was valued at US$ 423 million in the year 2024 and is projected to reach a revised size of US$ 574 million by 2031, growing at a CAGR of 4.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aprepitant API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant API.
The Aprepitant API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aprepitant API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aprepitant API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JUBILANT GENERICS LTD
PIRAMAL PHARMA LTD
MSN LABORATORIES PRIVATE LTD
HETERO DRUGS LTD
DR REDDYS LABORATORIES LTD
GLENMARK LIFE SCIENCES LTD
INKE SA
WISDOM PHARMACEUTICAL CO LTD
VIWIT PHARMACEUTICAL CO LTD
NAVINTA LLC
PHARMATHEN SA
SCINOPHARM TAIWAN LTD
AUROBINDO PHARMA LTD
WOCKHARDT BIO AG
SOLARA ACTIVE PHARMA SCIENCES LTD
OLON SPA
SHANDONG ANXIN PHARMACEUTICAL CO LTD
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
by Type
Purity≥99%
Purity<99%
by Application
Injection
Capsule
Emulsion
Oral Suspension
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aprepitant API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Aprepitant API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Aprepitant API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Aprepitant API Market Overview
1.1 Product Definition
1.2 Aprepitant API by Type
1.2.1 Global Aprepitant API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Aprepitant API by Application
1.3.1 Global Aprepitant API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Injection
1.3.3 Capsule
1.3.4 Emulsion
1.3.5 Oral Suspension
1.4 Global Market Growth Prospects
1.4.1 Global Aprepitant API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Aprepitant API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Aprepitant API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Aprepitant API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Aprepitant API Production Market Share by Manufacturers (2020-2025)
2.2 Global Aprepitant API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Aprepitant API, Industry Ranking, 2023 VS 2024
2.4 Global Aprepitant API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Aprepitant API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Aprepitant API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Aprepitant API, Product Offered and Application
2.8 Global Key Manufacturers of Aprepitant API, Date of Enter into This Industry
2.9 Aprepitant API Market Competitive Situation and Trends
2.9.1 Aprepitant API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Aprepitant API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Aprepitant API Production by Region
3.1 Global Aprepitant API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Aprepitant API Production Value by Region (2020-2031)
3.2.1 Global Aprepitant API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Aprepitant API by Region (2026-2031)
3.3 Global Aprepitant API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Aprepitant API Production Volume by Region (2020-2031)
3.4.1 Global Aprepitant API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Aprepitant API by Region (2026-2031)
3.5 Global Aprepitant API Market Price Analysis by Region (2020-2025)
3.6 Global Aprepitant API Production and Value, Year-over-Year Growth
3.6.1 North America Aprepitant API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Aprepitant API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Aprepitant API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Aprepitant API Production Value Estimates and Forecasts (2020-2031)
4 Aprepitant API Consumption by Region
4.1 Global Aprepitant API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Aprepitant API Consumption by Region (2020-2031)
4.2.1 Global Aprepitant API Consumption by Region (2020-2025)
4.2.2 Global Aprepitant API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Aprepitant API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Aprepitant API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Aprepitant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Aprepitant API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Aprepitant API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Aprepitant API Production by Type (2020-2031)
5.1.1 Global Aprepitant API Production by Type (2020-2025)
5.1.2 Global Aprepitant API Production by Type (2026-2031)
5.1.3 Global Aprepitant API Production Market Share by Type (2020-2031)
5.2 Global Aprepitant API Production Value by Type (2020-2031)
5.2.1 Global Aprepitant API Production Value by Type (2020-2025)
5.2.2 Global Aprepitant API Production Value by Type (2026-2031)
5.2.3 Global Aprepitant API Production Value Market Share by Type (2020-2031)
5.3 Global Aprepitant API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Aprepitant API Production by Application (2020-2031)
6.1.1 Global Aprepitant API Production by Application (2020-2025)
6.1.2 Global Aprepitant API Production by Application (2026-2031)
6.1.3 Global Aprepitant API Production Market Share by Application (2020-2031)
6.2 Global Aprepitant API Production Value by Application (2020-2031)
6.2.1 Global Aprepitant API Production Value by Application (2020-2025)
6.2.2 Global Aprepitant API Production Value by Application (2026-2031)
6.2.3 Global Aprepitant API Production Value Market Share by Application (2020-2031)
6.3 Global Aprepitant API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 JUBILANT GENERICS LTD
7.1.1 JUBILANT GENERICS LTD Aprepitant API Company Information
7.1.2 JUBILANT GENERICS LTD Aprepitant API Product Portfolio
7.1.3 JUBILANT GENERICS LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 JUBILANT GENERICS LTD Main Business and Markets Served
7.1.5 JUBILANT GENERICS LTD Recent Developments/Updates
7.2 PIRAMAL PHARMA LTD
7.2.1 PIRAMAL PHARMA LTD Aprepitant API Company Information
7.2.2 PIRAMAL PHARMA LTD Aprepitant API Product Portfolio
7.2.3 PIRAMAL PHARMA LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 PIRAMAL PHARMA LTD Main Business and Markets Served
7.2.5 PIRAMAL PHARMA LTD Recent Developments/Updates
7.3 MSN LABORATORIES PRIVATE LTD
7.3.1 MSN LABORATORIES PRIVATE LTD Aprepitant API Company Information
7.3.2 MSN LABORATORIES PRIVATE LTD Aprepitant API Product Portfolio
7.3.3 MSN LABORATORIES PRIVATE LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 MSN LABORATORIES PRIVATE LTD Main Business and Markets Served
7.3.5 MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
7.4 HETERO DRUGS LTD
7.4.1 HETERO DRUGS LTD Aprepitant API Company Information
7.4.2 HETERO DRUGS LTD Aprepitant API Product Portfolio
7.4.3 HETERO DRUGS LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 HETERO DRUGS LTD Main Business and Markets Served
7.4.5 HETERO DRUGS LTD Recent Developments/Updates
7.5 DR REDDYS LABORATORIES LTD
7.5.1 DR REDDYS LABORATORIES LTD Aprepitant API Company Information
7.5.2 DR REDDYS LABORATORIES LTD Aprepitant API Product Portfolio
7.5.3 DR REDDYS LABORATORIES LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 DR REDDYS LABORATORIES LTD Main Business and Markets Served
7.5.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
7.6 GLENMARK LIFE SCIENCES LTD
7.6.1 GLENMARK LIFE SCIENCES LTD Aprepitant API Company Information
7.6.2 GLENMARK LIFE SCIENCES LTD Aprepitant API Product Portfolio
7.6.3 GLENMARK LIFE SCIENCES LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 GLENMARK LIFE SCIENCES LTD Main Business and Markets Served
7.6.5 GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
7.7 INKE SA
7.7.1 INKE SA Aprepitant API Company Information
7.7.2 INKE SA Aprepitant API Product Portfolio
7.7.3 INKE SA Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 INKE SA Main Business and Markets Served
7.7.5 INKE SA Recent Developments/Updates
7.8 WISDOM PHARMACEUTICAL CO LTD
7.8.1 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Company Information
7.8.2 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.8.3 WISDOM PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 WISDOM PHARMACEUTICAL CO LTD Main Business and Markets Served
7.8.5 WISDOM PHARMACEUTICAL CO LTD Recent Developments/Updates
7.9 VIWIT PHARMACEUTICAL CO LTD
7.9.1 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Company Information
7.9.2 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.9.3 VIWIT PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 VIWIT PHARMACEUTICAL CO LTD Main Business and Markets Served
7.9.5 VIWIT PHARMACEUTICAL CO LTD Recent Developments/Updates
7.10 NAVINTA LLC
7.10.1 NAVINTA LLC Aprepitant API Company Information
7.10.2 NAVINTA LLC Aprepitant API Product Portfolio
7.10.3 NAVINTA LLC Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 NAVINTA LLC Main Business and Markets Served
7.10.5 NAVINTA LLC Recent Developments/Updates
7.11 PHARMATHEN SA
7.11.1 PHARMATHEN SA Aprepitant API Company Information
7.11.2 PHARMATHEN SA Aprepitant API Product Portfolio
7.11.3 PHARMATHEN SA Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 PHARMATHEN SA Main Business and Markets Served
7.11.5 PHARMATHEN SA Recent Developments/Updates
7.12 SCINOPHARM TAIWAN LTD
7.12.1 SCINOPHARM TAIWAN LTD Aprepitant API Company Information
7.12.2 SCINOPHARM TAIWAN LTD Aprepitant API Product Portfolio
7.12.3 SCINOPHARM TAIWAN LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 SCINOPHARM TAIWAN LTD Main Business and Markets Served
7.12.5 SCINOPHARM TAIWAN LTD Recent Developments/Updates
7.13 AUROBINDO PHARMA LTD
7.13.1 AUROBINDO PHARMA LTD Aprepitant API Company Information
7.13.2 AUROBINDO PHARMA LTD Aprepitant API Product Portfolio
7.13.3 AUROBINDO PHARMA LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 AUROBINDO PHARMA LTD Main Business and Markets Served
7.13.5 AUROBINDO PHARMA LTD Recent Developments/Updates
7.14 WOCKHARDT BIO AG
7.14.1 WOCKHARDT BIO AG Aprepitant API Company Information
7.14.2 WOCKHARDT BIO AG Aprepitant API Product Portfolio
7.14.3 WOCKHARDT BIO AG Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 WOCKHARDT BIO AG Main Business and Markets Served
7.14.5 WOCKHARDT BIO AG Recent Developments/Updates
7.15 SOLARA ACTIVE PHARMA SCIENCES LTD
7.15.1 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Company Information
7.15.2 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Product Portfolio
7.15.3 SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 SOLARA ACTIVE PHARMA SCIENCES LTD Main Business and Markets Served
7.15.5 SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
7.16 OLON SPA
7.16.1 OLON SPA Aprepitant API Company Information
7.16.2 OLON SPA Aprepitant API Product Portfolio
7.16.3 OLON SPA Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 OLON SPA Main Business and Markets Served
7.16.5 OLON SPA Recent Developments/Updates
7.17 SHANDONG ANXIN PHARMACEUTICAL CO LTD
7.17.1 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Company Information
7.17.2 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.17.3 SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.17.4 SHANDONG ANXIN PHARMACEUTICAL CO LTD Main Business and Markets Served
7.17.5 SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
7.18 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD
7.18.1 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Company Information
7.18.2 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Product Portfolio
7.18.3 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Production, Value, Price and Gross Margin (2020-2025)
7.18.4 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Main Business and Markets Served
7.18.5 LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Aprepitant API Industry Chain Analysis
8.2 Aprepitant API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Aprepitant API Production Mode & Process Analysis
8.4 Aprepitant API Sales and Marketing
8.4.1 Aprepitant API Sales Channels
8.4.2 Aprepitant API Distributors
8.5 Aprepitant API Customer Analysis
9 Aprepitant API Market Dynamics
9.1 Aprepitant API Industry Trends
9.2 Aprepitant API Market Drivers
9.3 Aprepitant API Market Challenges
9.4 Aprepitant API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Aprepitant API Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Aprepitant API Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Aprepitant API Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Aprepitant API Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Aprepitant API Production Market Share by Manufacturers (2020-2025)
Table 6. Global Aprepitant API Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Aprepitant API Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Aprepitant API, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Aprepitant API as of 2024)
Table 10. Global Market Aprepitant API Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Aprepitant API, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Aprepitant API, Product Offered and Application
Table 13. Global Key Manufacturers of Aprepitant API, Date of Enter into This Industry
Table 14. Global Aprepitant API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Aprepitant API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Aprepitant API Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Aprepitant API Production Value Market Share by Region (2020-2025)
Table 19. Global Aprepitant API Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Aprepitant API Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Aprepitant API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Aprepitant API Production (Tons) by Region (2020-2025)
Table 23. Global Aprepitant API Production Market Share by Region (2020-2025)
Table 24. Global Aprepitant API Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Aprepitant API Production Market Share Forecast by Region (2026-2031)
Table 26. Global Aprepitant API Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Aprepitant API Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Aprepitant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Aprepitant API Consumption by Region (2020-2025) & (Tons)
Table 30. Global Aprepitant API Consumption Market Share by Region (2020-2025)
Table 31. Global Aprepitant API Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Aprepitant API Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Aprepitant API Consumption by Country (2020-2025) & (Tons)
Table 35. North America Aprepitant API Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Aprepitant API Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Aprepitant API Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Aprepitant API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Aprepitant API Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Aprepitant API Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Aprepitant API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Aprepitant API Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Aprepitant API Consumption by Country (2026-2031) & (Tons)
Table 45. Global Aprepitant API Production (Tons) by Type (2020-2025)
Table 46. Global Aprepitant API Production (Tons) by Type (2026-2031)
Table 47. Global Aprepitant API Production Market Share by Type (2020-2025)
Table 48. Global Aprepitant API Production Market Share by Type (2026-2031)
Table 49. Global Aprepitant API Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Aprepitant API Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Aprepitant API Production Value Market Share by Type (2020-2025)
Table 52. Global Aprepitant API Production Value Market Share by Type (2026-2031)
Table 53. Global Aprepitant API Price (US$/Ton) by Type (2020-2025)
Table 54. Global Aprepitant API Price (US$/Ton) by Type (2026-2031)
Table 55. Global Aprepitant API Production (Tons) by Application (2020-2025)
Table 56. Global Aprepitant API Production (Tons) by Application (2026-2031)
Table 57. Global Aprepitant API Production Market Share by Application (2020-2025)
Table 58. Global Aprepitant API Production Market Share by Application (2026-2031)
Table 59. Global Aprepitant API Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Aprepitant API Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Aprepitant API Production Value Market Share by Application (2020-2025)
Table 62. Global Aprepitant API Production Value Market Share by Application (2026-2031)
Table 63. Global Aprepitant API Price (US$/Ton) by Application (2020-2025)
Table 64. Global Aprepitant API Price (US$/Ton) by Application (2026-2031)
Table 65. JUBILANT GENERICS LTD Aprepitant API Company Information
Table 66. JUBILANT GENERICS LTD Aprepitant API Specification and Application
Table 67. JUBILANT GENERICS LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. JUBILANT GENERICS LTD Main Business and Markets Served
Table 69. JUBILANT GENERICS LTD Recent Developments/Updates
Table 70. PIRAMAL PHARMA LTD Aprepitant API Company Information
Table 71. PIRAMAL PHARMA LTD Aprepitant API Specification and Application
Table 72. PIRAMAL PHARMA LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. PIRAMAL PHARMA LTD Main Business and Markets Served
Table 74. PIRAMAL PHARMA LTD Recent Developments/Updates
Table 75. MSN LABORATORIES PRIVATE LTD Aprepitant API Company Information
Table 76. MSN LABORATORIES PRIVATE LTD Aprepitant API Specification and Application
Table 77. MSN LABORATORIES PRIVATE LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. MSN LABORATORIES PRIVATE LTD Main Business and Markets Served
Table 79. MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
Table 80. HETERO DRUGS LTD Aprepitant API Company Information
Table 81. HETERO DRUGS LTD Aprepitant API Specification and Application
Table 82. HETERO DRUGS LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. HETERO DRUGS LTD Main Business and Markets Served
Table 84. HETERO DRUGS LTD Recent Developments/Updates
Table 85. DR REDDYS LABORATORIES LTD Aprepitant API Company Information
Table 86. DR REDDYS LABORATORIES LTD Aprepitant API Specification and Application
Table 87. DR REDDYS LABORATORIES LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. DR REDDYS LABORATORIES LTD Main Business and Markets Served
Table 89. DR REDDYS LABORATORIES LTD Recent Developments/Updates
Table 90. GLENMARK LIFE SCIENCES LTD Aprepitant API Company Information
Table 91. GLENMARK LIFE SCIENCES LTD Aprepitant API Specification and Application
Table 92. GLENMARK LIFE SCIENCES LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. GLENMARK LIFE SCIENCES LTD Main Business and Markets Served
Table 94. GLENMARK LIFE SCIENCES LTD Recent Developments/Updates
Table 95. INKE SA Aprepitant API Company Information
Table 96. INKE SA Aprepitant API Specification and Application
Table 97. INKE SA Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. INKE SA Main Business and Markets Served
Table 99. INKE SA Recent Developments/Updates
Table 100. WISDOM PHARMACEUTICAL CO LTD Aprepitant API Company Information
Table 101. WISDOM PHARMACEUTICAL CO LTD Aprepitant API Specification and Application
Table 102. WISDOM PHARMACEUTICAL CO LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. WISDOM PHARMACEUTICAL CO LTD Main Business and Markets Served
Table 104. WISDOM PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 105. VIWIT PHARMACEUTICAL CO LTD Aprepitant API Company Information
Table 106. VIWIT PHARMACEUTICAL CO LTD Aprepitant API Specification and Application
Table 107. VIWIT PHARMACEUTICAL CO LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. VIWIT PHARMACEUTICAL CO LTD Main Business and Markets Served
Table 109. VIWIT PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 110. NAVINTA LLC Aprepitant API Company Information
Table 111. NAVINTA LLC Aprepitant API Specification and Application
Table 112. NAVINTA LLC Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. NAVINTA LLC Main Business and Markets Served
Table 114. NAVINTA LLC Recent Developments/Updates
Table 115. PHARMATHEN SA Aprepitant API Company Information
Table 116. PHARMATHEN SA Aprepitant API Specification and Application
Table 117. PHARMATHEN SA Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. PHARMATHEN SA Main Business and Markets Served
Table 119. PHARMATHEN SA Recent Developments/Updates
Table 120. SCINOPHARM TAIWAN LTD Aprepitant API Company Information
Table 121. SCINOPHARM TAIWAN LTD Aprepitant API Specification and Application
Table 122. SCINOPHARM TAIWAN LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. SCINOPHARM TAIWAN LTD Main Business and Markets Served
Table 124. SCINOPHARM TAIWAN LTD Recent Developments/Updates
Table 125. AUROBINDO PHARMA LTD Aprepitant API Company Information
Table 126. AUROBINDO PHARMA LTD Aprepitant API Specification and Application
Table 127. AUROBINDO PHARMA LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. AUROBINDO PHARMA LTD Main Business and Markets Served
Table 129. AUROBINDO PHARMA LTD Recent Developments/Updates
Table 130. WOCKHARDT BIO AG Aprepitant API Company Information
Table 131. WOCKHARDT BIO AG Aprepitant API Specification and Application
Table 132. WOCKHARDT BIO AG Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. WOCKHARDT BIO AG Main Business and Markets Served
Table 134. WOCKHARDT BIO AG Recent Developments/Updates
Table 135. SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Company Information
Table 136. SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Specification and Application
Table 137. SOLARA ACTIVE PHARMA SCIENCES LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. SOLARA ACTIVE PHARMA SCIENCES LTD Main Business and Markets Served
Table 139. SOLARA ACTIVE PHARMA SCIENCES LTD Recent Developments/Updates
Table 140. OLON SPA Aprepitant API Company Information
Table 141. OLON SPA Aprepitant API Specification and Application
Table 142. OLON SPA Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. OLON SPA Main Business and Markets Served
Table 144. OLON SPA Recent Developments/Updates
Table 145. SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Company Information
Table 146. SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Specification and Application
Table 147. SHANDONG ANXIN PHARMACEUTICAL CO LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. SHANDONG ANXIN PHARMACEUTICAL CO LTD Main Business and Markets Served
Table 149. SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 150. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Company Information
Table 151. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Specification and Application
Table 152. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Aprepitant API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Main Business and Markets Served
Table 154. LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Aprepitant API Distributors List
Table 158. Aprepitant API Customers List
Table 159. Aprepitant API Market Trends
Table 160. Aprepitant API Market Drivers
Table 161. Aprepitant API Market Challenges
Table 162. Aprepitant API Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Aprepitant API
Figure 2. Global Aprepitant API Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Aprepitant API Market Share by Type: 2024 VS 2031
Figure 4. Purity≥99% Product Picture
Figure 5. Purity<99% Product Picture
Figure 6. Global Aprepitant API Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Aprepitant API Market Share by Application: 2024 VS 2031
Figure 8. Injection
Figure 9. Capsule
Figure 10. Emulsion
Figure 11. Oral Suspension
Figure 12. Global Aprepitant API Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Aprepitant API Production Value (US$ Million) & (2020-2031)
Figure 14. Global Aprepitant API Production Capacity (Tons) & (2020-2031)
Figure 15. Global Aprepitant API Production (Tons) & (2020-2031)
Figure 16. Global Aprepitant API Average Price (US$/Ton) & (2020-2031)
Figure 17. Aprepitant API Report Years Considered
Figure 18. Aprepitant API Production Share by Manufacturers in 2024
Figure 19. Global Aprepitant API Production Value Share by Manufacturers (2024)
Figure 20. Aprepitant API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. The Global 5 and 10 Largest Players: Market Share by Aprepitant API Revenue in 2024
Figure 22. Global Aprepitant API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 23. Global Aprepitant API Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. Global Aprepitant API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 25. Global Aprepitant API Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 26. North America Aprepitant API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Aprepitant API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. China Aprepitant API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Japan Aprepitant API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Global Aprepitant API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 31. Global Aprepitant API Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 32. North America Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 33. North America Aprepitant API Consumption Market Share by Country (2020-2031)
Figure 34. U.S. Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Canada Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Europe Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Europe Aprepitant API Consumption Market Share by Country (2020-2031)
Figure 38. Germany Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. France Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. U.K. Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Italy Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Russia Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Asia Pacific Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Asia Pacific Aprepitant API Consumption Market Share by Region (2020-2031)
Figure 45. China Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. Japan Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. South Korea Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. China Taiwan Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. Southeast Asia Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. India Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Latin America, Middle East & Africa Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Latin America, Middle East & Africa Aprepitant API Consumption Market Share by Country (2020-2031)
Figure 53. Mexico Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Brazil Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Turkey Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. GCC Countries Aprepitant API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. Global Production Market Share of Aprepitant API by Type (2020-2031)
Figure 58. Global Production Value Market Share of Aprepitant API by Type (2020-2031)
Figure 59. Global Aprepitant API Price (US$/Ton) by Type (2020-2031)
Figure 60. Global Production Market Share of Aprepitant API by Application (2020-2031)
Figure 61. Global Production Value Market Share of Aprepitant API by Application (2020-2031)
Figure 62. Global Aprepitant API Price (US$/Ton) by Application (2020-2031)
Figure 63. Aprepitant API Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
